Cypress Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Cypress Advisory Group's AMGN Position: Q2 2026 in Review
Cypress Advisory Group held its Amgen (AMGN) position steady in Q2 2026 at 614 shares worth $222K. The position accounts for 0.17% of the portfolio, ranked #79.
Cypress Advisory Group first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 1,338 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cypress Advisory Group held 614 shares of Amgen worth $222K as of Q2 2026.
- Cypress Advisory Group left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.17% of Cypress Advisory Group's portfolio in Q2 2026, its #79 holding.
- Cypress Advisory Group first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- 1,338 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cypress Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.